Kala Bio adds healthcare operator Yenvy Truong to advisory team

Kala Bio, Inc. (Nasdaq: KALA) announced that Yenvy Truong, founder of The LSM Group, has joined the company's advisory team, according to a press release dated Sept. 17, 2026.

Truong will support management as Kala Bio grows its existing business and evaluates expansion opportunities, including potential acquisitions. She serves as an advisor and is neither an officer nor an employee of the company.

Truong has approximately two decades of experience in healthcare operations, including building and operating diagnostic laboratories. She has founded, scaled, and advised healthcare and life sciences companies across genomics, longevity, remote patient monitoring, digital musculoskeletal care, and metabolic medicine, through transactions totaling more than $200 million in combined transaction and enterprise value.

Kala Bio said it is focused on expanding its business in diagnostics, genetic testing, and preventive and connected health, including through an exclusive distribution and reseller agreement with Virotek Inc.

"Yenvy has built and run diagnostics and biotech/healthcare businesses and understands what it takes to scale them," said Avi Minkowitz, Chief Executive Officer of Kala Bio. "She gives us a clearer view of where the right opportunities are, whether that is a new service, a new partner, or a company we bring into KALA."

You May Also Be Interested In

• Buzbuzian Capital invests $300,000 in Getchell Gold Corp.
• KeyBanc Upgrades Generac Holdings (GNRC) to Overweight
• IonQ secures up to $300M DARPA deal to validate quantum systems